Ironwood Pharmaceuticals | IRWD - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Almirall EUR 337.77M 14.83M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
Ardelyx USD 68M 25.28M 2025-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 8.14B 1.08B 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Exact Sciences USD 956M 166.96M 2025-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Incyte USD 3.58B 650.78M 2025-12
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
MacroGenics USD 57.22M 22.91M 2025-12
Moderna USD 2.6B 1.46B 2025-12
Myriad Genetics USD 149.6M 4.2M 2025-12
Pacira USD 158.54M 10.96M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Puma Biotechnology USD 53.52M 1.14M 2025-09
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Takeda JPY 654.94B 26.55B 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12